INSIGHTS ON DRUG DEVELOPMENT
-
Patented Process For Intermediates Useful For Deucravacitinib
Discover how this patented synthetic approach to Deucravacitinib intermediates can improve yield, simplify purification, and support scalable, regulatory-aligned manufacturing.
-
Glucagon-Like Peptide-1 (GLP-1) Analogues Applications Notebook
View this collection of application notes about the chromatographic analysis and purification of GLP-1 analogues, including Semaglutide, Tirzepatide, Liraglutide, and Exenatide.
-
Assess Biomolecular Stability With Confidence
Gain deeper insight into biomolecular stability with highly sensitive thermal analysis. Thermodynamic measurements help evaluate formulation performance, detect structural changes, and more.
-
Process Intensification: Your Guide To "Doing More With Less"
Explore innovative strategies in process intensification to boost mAb production and hear from industry experts as they share solutions for scaling efficiency and navigating regulatory challenges.
-
Versatile Lipid Nanoparticle Platform For Efficient Gene Editing6/3/2025
Lipid nanoparticles enable efficient gene editing in hard-to-transfect cells like T-cells and blood stem cells, which offers scalable, clinically relevant methods for developing advanced therapies for cancer and rare diseases.
-
The Work That Never Shows Up In Your QA Plan4/29/2026
Manual audit prep consumes valuable quality capacity. Transitioning to continuous readiness automates evidence generation and scales compliance efficiently.
-
Advancements In GLP-1 Analog Formulation: Overcoming Challenges2/3/2025
Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.
-
Chemoenzymatic N-glycan Conjugation Of Native mAbs Provides Homogeneous, Efficacious ADCs9/3/2026
A chemoenzymatic two-stage protocol enables DAR2 ADCs from native, non-engineered mAbs via glycan remodeling at Asn-297 and copper-free click chemistry, with in vivo efficacy outperforming a comparable marketed ADC.
-
How To Capture Growth In The Expanding Metabolic Drug Market12/2/2025
Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.
DRUG DEVELOPMENT SOLUTIONS
-
3D organoids offer enhanced physiological relevance and are ready to use from cryopreserved vials. Discover how they can streamline your research with high-quality and comprehensive support.
-
Learn about a solution for next-generation in vitro models that leverages cutting-edge organ-on-a-chip technology to emulate human biology with unparalleled accuracy compared to conventional models.
-
DSC and ITC offer deep insights into molecular binding and structural stability, which help researchers uncover thermodynamic drivers and domain-level behavior essential for protein characterization.
-
One MS Software for All Your Mass Spectral Data Analysis and Management
ACD/MS Workbook Suite is an all-in-one package for MS data handling.
- Process MS, LC/MS, and GC/MS data acquired with instruments from any major vendor
- Auto-annotate peaks and associate them with compound structures
- Identify unknowns by deconvoluting spectra and searching databases for spectral matches
- Create easily shareable and searchable spectral databases
-
A facility overview highlighting solubility enhancement and advanced drug delivery capabilities, including a predictive formulation platform and project timeline benchmarks.